Omada Health Enhances Clinical Advisory Board to Further Advance Clinical Excellence

Omada’s Clinical Advisory Board demonstrates its commitment to rigorous clinical evaluation and helps underscore the impact of its behavior change programs

Omada Health, the virtual between-visit healthcare provider, today announced the members of its Clinical Advisory Board, who together provide a broad spectrum of industry-leading perspectives in the areas of clinical services and population health.

The Omada Health Clinical Advisory Board provides expert advice and guidance to Omada on opportunities for clinical improvements, including identifying areas for innovation, supporting evidence generation, and helping to ensure that Omada's clinical programs and products are aligned with high standards of care.

Healthcare industry executives who have joined Omada’s Clinical Advisory Board include:

• Ellen Beckjord, PhD, MPH: Vice President, Population Health and Clinical Optimization, UPMC Health Plan
• Lisa Fitzpatrick, MD, MPA, MPH: CEO Grapevine Health, Medical Epidemiologist
• Geeta Nayyar, MD, MBA: Chief Medical Officer, RadiantGraph and WSJ Best Selling Author
• Andrew Rundle, DrPH, FNYAM: Professor of Epidemiology, Columbia University
• Anil Sipahimalani, MD: Medical Director, Cigna

“In a shifting healthcare landscape inundated with more digital tools than ever – especially for cardiovascular health amid the GLP-1 boom – these programs vary widely in effectiveness for the patients who need them the most,” said Anil Sipahimalani, MD, Medical Director, Cigna. “I’m honored to support Omada in furthering their long history of utilizing robust clinical evidence to treat patients in between provider visits and support in identifying new opportunities to enhance the product for optimal patient outcomes.”

The Board will advise on research, including the Omada Insights Lab, which builds on more than a decade of insights and 29 peer-reviewed publications assessing the efficacy of behavior change programs to improve chronic disease management.

Such research includes Omada’s recent oral presentation at the American Heart Association’s EPI | Lifestyle 2025 conference, where findings demonstrate that Hypertension and Diabetes program members had fewer inpatient and emergency room encounters at 6 and 12 months in comparison to similar patients receiving usual care.

In addition, members of the Clinical Advisory Board will also advise on further research conducted within Omada’s ANSWERS (ANalyzing Success of WEight medication with Real-world evidence and Stats) Initiative, launched last year to evaluate factors associated with medication usage and the relationship between lifestyle program participation on long-term outcomes of weight health, with and without GLP-1 use, at a population level.

“We’re thrilled to have these incredibly experienced clinical and research leaders in healthcare supporting Omada’s continued investment in industry-leading, peer-reviewed research and real-world insights,” said Sarah Linke, PhD, MPH, Senior Director, Clinical & Translational Research, Omada Health. “Their collective expertise will help us further demonstrate the effectiveness of our behavior change programs for long-term cardiometabolic health. We believe the future of healthcare is virtual, but only through thoughtful, robust evaluation can we guarantee that this future is one of improved outcomes, access, satisfaction, and equity for all stakeholders.”

Additional research from Omada Health will be featured in poster presentations at the Society for Behavioral Medicine Annual Meeting and Scientific Sessions, to be held March 26-29, 2025 in San Francisco, California.

Omada Health

Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.

The foundation of Omada’s success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work. An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement’s Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250319513611/en/